White, chief executive at Combat Medical, a UK based global company dedicated to bringing hyperthermic treatments to patients ...

Cloudbreak Pharma, the Irvine, California-based ophthalmic drug company, said its multi-kinase inhibitor eye drop CBT-001 met ...

Johnson & Johnson said the US Food and Drug Administration (FDA) has granted accelerated approval to Rybrevant Faspro ...

For a pharmaceutical company waiting on a US approval decision, the PDUFA date is closely watched. It marks when the US ...

The US Centers for Medicare & Medicaid Services (CMS) is establishing a permanent framework for negotiating prices of high-cost drugs.

US clinical-stage biotech Evommune and Hinova Pharmaceuticals have entered into an exclusive license agreement granting ...

Swiss specialty pharmaceutical company Dipharma has acquired long-time UK partner LogixX Pharma, bringing the commercial ...

For a generic drug company in the USA, being first is not simply a matter of getting a copy of a medicine through the US ...

USA-based mRNA vaccines company Moderna announced that Health Canada has authorized mFLUSIVA (Influenza mRNA vaccine; mRNA-1010) and mCOFLU (Combined Influenza and COVID-19 mRNA vaccine; mRNA-1083) ...

Samsung Bioepis, the South Korean biosimilar developer and wholly-owned subsidiary of Samsung Epis Holdings, has presented ...

Moderna (Nasdaq: MRNA) today reported financial results for the third quarter of 2026, showing a return to profit. Total revenue for the third quarter of 2026 increased 29% to $1.3 billion, compared ...

The Muscular Dystrophy Association (MDA), the US patient and research organization, has said it is seeking more information ...